Editing false positives from cancer dependency maps drawn with CRISPR – Medical Xpress
Medical Xpress |
Editing false positives from cancer dependency maps drawn with CRISPR
Medical Xpress Genome-scale CRISPR-based knockout screens are powerful tools for pinpointing cells’ genetic dependencies—that is, genes that cells require for their survival and/or proliferation. However, such CRISPR screens are sensitive to a phenomenon called the … |
Boston Business Journal |
Sarepta jumps into the CRISPR fray with Duke gene-editing pact
Boston Business Journal Sarepta (Nasdaq: SRPT) said it had reached an agreement to exclusively license technology related to CRISPR/Cas9 from Duke University. Researchers there, led by Dr. Charles Gersbach, have shown that the technology can be used in mice to remove … Expanding its preclinical attack on Duchenne MD, Sarepta grabs a license for Duke’s CRISPR techEndpoints News Sarepta Therapeutics (SRPT) Signs Exclusive Global Collaboration with Duke University for Gene Editing CRISPR …StreetInsider.com Sarepta inks research collaboration with Duke University for use of gene editing technology to restore dystrophin …Seeking Alpha |
|
Sarepta turns to Duke’s CRISPR work for next-gen DMD therapies
FierceBiotech Sarepta says it will collaborate with Gersbach’s lab to “advance the CRISPR platform and take the lead on clinical development.” It’s signed a series of similar deals, including in gene therapy, to help it create better, broader treatments for the … |
|
Sarepta turns to Duke’s CRISPR work for next-gen DMD therapies
FierceBiotech Sarepta says it will collaborate with Gersbach’s lab to “advance the CRISPR platform and take the lead on clinical development.” It’s signed a series of similar deals, including in gene therapy, to help it create better, broader treatments for the … |
|
Sarepta turns to Duke’s CRISPR work for next-gen DMD therapies
FierceBiotech Sarepta says it will collaborate with Gersbach’s lab to “advance the CRISPR platform and take the lead on clinical development.” It’s signed a series of similar deals, including in gene therapy, to help it create better, broader treatments for the … |